20 results
PRE 14A
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Preliminary proxy
4:03pm
an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. In considering
8-K/A
EX-10.3
x182zgw0
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
DEF 14A
zv0vd166c h1jvgo2j
29 Apr 21
Definitive proxy
5:03pm
10-K
45cxr637z8awaxdpip
3 Mar 21
Annual report
9:00am
10-Q
83xa3wf
12 Nov 20
Quarterly report
4:27pm
10-Q
EX-10.7
7t5t0
12 Nov 20
Quarterly report
4:27pm
424B4
dwngj7 1aqhys
25 Sep 20
Prospectus supplement with pricing info
12:00am
S-1/A
fr9 kpgg8rr
8 Sep 20
IPO registration (amended)
4:43pm
S-1
3ngc2fn4 m76
2 Sep 20
IPO registration
5:02pm
DRS
p8bkhm
3 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next